Kory Wentworth

Kory Wentworth

Director of Finance/CFO at ENTRADA THERAPEUTICS, INC.

Net worth: 275 211 $ as of 2024-05-30

45 year
Health Technology
Consumer Services
Commercial Services

Profile

Kory James Wentworth's career history includes current and former positions as well as education.
Currently, he is the Chief Financial Officer & Treasurer at Entrada Therapeutics, Inc. Previously, he held the position of Executive Director & Corporate Controller at Alexion Pharmaceuticals, Inc. from 2008 to 2017.
From 2017 to 2020, he worked as Treasurer & Vice President-Finance at bluebird bio, Inc. Prior to that, he was an Audit Manager at PricewaterhouseCoopers LLP from 2002 to 2008.
Mr. Wentworth obtained his undergraduate degree from Susquehanna University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-04-15 17,790 ( 0.05% ) 275 211 $ 2024-05-30

Kory Wentworth active positions

CompaniesPositionStart
ENTRADA THERAPEUTICS, INC. Director of Finance/CFO 2020-10-31
All active positions of Kory Wentworth

Former positions of Kory Wentworth

CompaniesPositionEnd
BLUEBIRD BIO, INC. Comptroller/Controller/Auditor 2020-09-07
ALEXION PHARMACEUTICALS, INC. Director/Board Member 2017-11-30
Comptroller/Controller/Auditor 2008-11-30
See the detail of Kory Wentworth's experience

Training of Kory Wentworth

Susquehanna University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kory Wentworth's experience

Connections

100 +

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
BLUEBIRD BIO, INC.

Health Technology

ENTRADA THERAPEUTICS, INC.

Health Technology

Private companies2

Health Technology

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Kory Wentworth